Showing results (561-570 of 9,003) with videos related to

Sort By:
Pageof 901
European Journal of Clinical Pharmacology|January 1, 1983
Procaine hydrolysis defect in uraemia does not appear to be due to carbamylation of plasma esterasesR Calvo, R Carlos, S Erill
European Journal of Clinical Pharmacology|January 1, 1989
Elimination and haemodynamic effects of nitrendipine in patients with chronic renal failureT Ankermann, U Osterkamp, S R Santos, et al.
European Journal of Clinical Pharmacology|January 1, 1989
Pharmacokinetics of nitrendipine in terminal renal failureL van Bortel, R Böhm, J Mooy, et al.
European Journal of Clinical Pharmacology|January 1, 1989
In vitro protein binding of propafenone in normal and uraemic human seraG L Chan, J E Axelson, J D Price, et al.
European Journal of Clinical Pharmacology|January 1, 1982
Transplacental passage and breast milk concentrations of hydralazineH Liedholm, E Wåhlin-Boll, A Hanson, et al.
European Journal of Clinical Pharmacology|January 1, 1981
Skeletal muscle digoxin concentration during digitalization and during withdrawal of digoxin treatmentT Jogestrand, F Ericsson, K Sundqvist
European Journal of Clinical Pharmacology|January 1, 1981
Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemideE Keller, G Hoppe-Seyler, R Mumm, et al.
European Journal of Clinical Pharmacology|January 1, 1981
Effect of food on the absorption of hydralazine in manR J Walden, R Hernandez, D Witts, et al.
European Journal of Clinical Pharmacology|January 1, 1981
Carbamazepine: a clinical biopharmaceutical studyM Dam, J Christiansen, C B Kristensen, et al.
European Journal of Clinical Pharmacology|January 1, 1984
Comparison of plasma levels of canrenone and metabolites after base hydrolysis in young and elderly subjects following single and multiple doses of spironolactoneP C Ho, D W Bourne, E J Triggs, et al.
Pageof 901